A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Andreas Andersen
Filip Krag Knop
Tina Vilsbøll
机构：
[1] University of Copenhagen,Steno Diabetes Center Copenhagen, Gentofte Hospital
[2] University of Copenhagen,Center for Clinical Metabolic Research, Gentofte Hospital
[3] University of Copenhagen,Department of Clinical Medicine, Faculty of Health and Medical Sciences
[4] University of Copenhagen,Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences
来源：
Drugs | 2021年 / 81卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1003 / 1030
页数：27
相关论文
共 50 条
  • [1] A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
    Andersen, Andreas
    Knop, Filip Krag
    Vilsboll, Tina
    DRUGS, 2021, 81 (09) : 1003 - 1030
  • [2] Oral semaglutide for the treatment of type 2 diabetes
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 133 - 141
  • [3] Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
    Lunati, Maria Elena
    Cimino, Vincenzo
    Bernasconi, Davide
    Gandolfi, Alessandra
    Morpurgo, Paola Silvia
    Tinari, Camilla
    Lazzaroni, Elisa
    Baruffaldi, Laura
    Muratori, Milena
    Montefusco, Laura
    Pastore, Ida
    Rossi, Antonio
    Franzetti, Ivano Giuseppe
    Muratori, Fabrizio
    Manfrini, Roberto
    Disoteo, Olga Eugenia
    Terranova, Rosa
    Desenzani, Paolo
    Girelli, Angela
    Ghelardi, Renata
    D'Addio, Francesca
    Ben Nasr, Moufida
    Berra, Cesare
    Folli, Franco
    Bucciarelli, Loredana
    Fiorina, Paolo
    PHARMACOLOGICAL RESEARCH, 2024, 199
  • [4] Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus
    Semenya, Afi Mansa
    Wilson, Stephen A.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (10) : 627 - 628
  • [5] Oral semaglutide in type 2 diabetes
    Anderson, Sarah L.
    Beutel, Trevor R.
    Trujillo, Jennifer M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (04)
  • [6] Pharmacokinetics and Clinical Implications of Oral Semaglutide for Type 2 Diabetes Mellitus
    Clements, Jennifer N.
    Isaacs, Diana
    Hartman, Rachel E.
    Gambill, Kennedy
    CLINICAL PHARMACOKINETICS, 2021, 60 (02) : 153 - 163
  • [7] Pharmacokinetics and Clinical Implications of Oral Semaglutide for Type 2 Diabetes Mellitus
    Jennifer N. Clements
    Diana Isaacs
    Rachel E. Hartman
    Kennedy Gambill
    Clinical Pharmacokinetics, 2021, 60 : 153 - 163
  • [8] Oral Semaglutide (Rybelsus) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1583): : 166 - 168
  • [9] The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
    Mads Frederik Rasmussen
    Diabetology International, 2020, 11 : 76 - 86
  • [10] A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
    Vanita R. Aroda
    Lawrence Blonde
    Richard E. Pratley
    Reviews in Endocrine and Metabolic Disorders, 2022, 23 : 979 - 994
12345